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X-ray diffractionReaction of 2,6-diacetylpyridine bis(4N-o-tolylthiosemicarbazone), H2L1, with K2PtCl4 and further recrystalliza-
tion in DMSO/MeOH of the [PtL1] complex obtained, led to the isolation of the novel platinum complex, [PtL2],
which was structurally characterized by single crystal X-ray diffraction. The molecular structure shows that
the ligand has undergone an unexpected chemical transformation viz. reduction of one of the terminal phenyl
rings into cyclohexyl. The resulted asymmetrical ligand acts a dianionic tetradentate donor, coordinating to
the platinum(II) center in a square planar geometry through the Npyridinic atom and the Niminic and the S atoms
from one thiosemicarbazone arm, the fourth coordination position is occupied by the Nhydrazinic atom of the
other arm.
© 2012 Published by Elsevier B.V.30161
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87Thiosemicarbazones (R1R2C_N\NH\C(S)\NR3R4) are an im-
portant and versatile type of ligands due to the potential donor
atoms that they possess, among which sulfur is of paramount im-
portance in the metal–ligand linkage. Moreover the π delocalization
and conﬁgurational ﬂexibility create the possibility of a variety of
coordination modes [1–3].
The coordination capacity of thiosemicarbazones can be further in-
creased, if the parent aldehyde or ketone contains additional functional
group in a position suitable for chelation. Particularly, compounds in
which the thiosemicarbazone side-chain is attached in the α position
to an N-heterocyclic ring, namely α-N-heterocyclic thiosemicarbazones,
are strong metal chelating agents and have been reported to be among
themost effective ribonucleotide reductase (RR) inhibitors yet identiﬁed
[4]. Pyridine-2-carbaldehyde thiosemicarbazonewas theﬁrstmember of
this class reported to have carcinostatic effects and since then many
α-N-heterocyclic thiosemicarbazones and their metal complexes have
shown anticancer activity against a wide spectrum of tumor cell lines.
Currently, the 3-aminopyridine-2-carboxaldehyde thiosemicarbazone
(Triapine, Vion Pharmaceuticals, New Haven, CT) is being evaluated in
human phase II clinical trials as an antineoplastic therapeutic [5–7].
Although not as intensely studied as the mono(thiosemicarbazones),
the α-N-heterocyclic bis(thiosemicarbazones) having the two thiosemi-
carbazone moieties positioned possess a variety of ﬂexible donor sets
and are capable of adopting various coordination modes, leading to
enormous structural diversity of their complexes. For example, in the
literature a series of dinuclear zinc complexes have been found
derived from 2,6-diacetylpyridine bis(thiosemicarbazone) ligands88
89
90
34 914974833.
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mmun. (2012), http://dx.doshowing [7+7], [6+6], [6+4] and [4+4] coordination environ-
ments [8–11]. However no structural information about d8 metal
complexes bearing 2,6-diacetylpyridine bis(thiosemicarbazone)
ligands has been encountered in the bibliography.
As a part of a program concerning the behavior of α-N-heterocyclic
bis(thiosemicarbazones)wehave published structural studies of a series
of palladium(II) and platinum(II) complexes derived from 3,5-diacetyl-
1,2,4-triazol-bis(thiosemicarbazones)[12–18]. In these complexes, the
square-planar coordination geometry of the centralmetal ions is provid-
ed by one N atom of the heterocyclic ring, the Niminic and S atoms of one
thiosemicarbazone arm and the S of the other thiosemicarbazone arm
(dimer complexes) or the P atom of the PPh3 coligand (mononuclear
complexes).
To extend the knowledge in this research ﬁeld, particularly with re-
spect to the coordination properties of theα-N-heterocyclic bis(thiosemi-
carbazones) and the stereochemistry and molecular structure of the
complexes, we undertook the study of platinum(II) complexes derived
from 2,6-diacetylpyridine bis(4N-substituted thiosemicarbazones). Here
we report on the synthesis, characterization and crystal structure of a
new Pt(II) complex derived from an asymmetric 2,6-diacetylpyridine
bis(4N-substituted thiosemicarbazone) ligand.
The novel ligand 2,6-diacetylpyridine bis(4N-o-tolylthiosemicarba-
zone), H2L1, was synthesized by reﬂuxing an ethanolic solution (20 mL)
of 2,6-diacetylpyridine (1 mmol) with 4N-o-tolylthiosemicarbazide
(2 mmol), which was prepared as described in reference [18], for 5 h
and then was left to stand in ambient temperature. The solution was re-
duced to half volume and the pale yellow solid formed was ﬁltered,
washed with cold EtOH and Et2O and dried in vacuo. The ligand was
characterized by elemental analysis and FAB spectrometry as well as by
IR and 1H NMR spectroscopy [19].complex of an asymmetric 2,6-diacetylpyridine bis(4N-substituted
i.org/10.1016/j.inoche.2012.10.022
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Fig. 1. Molecular structure of platinum(II) complex [PtL2].
2 A.I. Matesanz, P. Souza / Inorganic Chemistry Communications xxx (2012) xxx–xxxReaction of methanolic suspension (20 mL) of H2L1 ligand
(1.0 mmol) with K2PtCl4 (1.0 mmol) in water for 5 h at room tem-
perature yielded a brown precipitate which was ﬁltered, washed
with MeOH and Et2O, puriﬁed by crystallization from DMSO and
dried in vacuo. Analytical and spectroscopic characterization [20]
was consistent with the formation of the expected neutral [PtL1]
complex (Scheme 1).
Further recrystallization of [PtL1] from DMSO/MeOH led to the iso-
lation of good quality single crystals which were studied by X-ray dif-
fraction techniques [21]. The structural analysis allowed us to identify
a new platinum(II) complex, [PtL2], in which the 2,6-diacetylpyridine
bis(4N-o-tolylthiosemicarbazone) ligand has undergone an unexpected
chemical transformation viz. reduction of one of the terminal phenyl
rings into cyclohexyl.
Conventional hydrogenation reactions have implicit use of hydrogen
as a reactant. However it is possible that in the presence of a metal com-
plex, a donor hydrogenmolecule transfers to a substratewhich acts as an
acceptor. The donor molecules, which undergo dehydrogenation are
often the reaction solvents and the catalysts are usually derived from
platinum group metals with nitrogen or phosphorus donating ligands
with the Wilkinson's catalyst [RhCl(PPh3)3] being the most prominent
[22–24].
By inspection of the literature a few examples of thiosemi-
carbazone metal complexes exhibiting catalytic activity have been
found. The fundamental features of these catalysts are the presence,
in the complexes, of stabilizing ﬁve membered chelate rings as well
as the presence of a labile coordinating bond prone to dissociate to
provide an available coordination site [25–27].
In our case, the platinum complex [PtL1] contains two ﬁve mem-
bered chelate rings as well as a more rigid and therefore less stable
six membered chelate ring. Although further studies are necessary
in order to identify the reductant, a possible candidate could be
MeOH employed as solvent.
Since we have noticed that platinum(II) complexes derived of
3,5-diacetyl-1,2,4-triazol bis(4N-o-tolylthiosemicarbazone) ligand have
shown a notable antitumor activity [17] we analyzed the cytotoxic prop-
erties of the new complex [PtL2] by testing its antiproliferative activity in
vitro against ﬁve human cancer cell lines: NCI-H460 (non-small cell lung
cancer), HepG2 (hepatocellular carcinoma), MCF-7 (breast cancer),
A2780 and A2780cisR (epithelial ovarian cancer) which are among the
lines used in theNCI to identify novel potential anticancer drugs. Surpris-
ingly, the platinum(II) complex [PtL2] shows at 100 μM concentration,
a very low cellular growth inhibition (b50%) and therefore did not
have evaluable cytotoxicity (IC50>100 μM). The substitution of the
N-heterocyclic ring (1,2,4-triazol versus pyridine) as well as the hydro-
genation on the peripheral tolyl substituent seems to be factors that
inﬂuence both structure and cytotoxicity.
The molecular structure of the neutral complex [PtL2], which crys-
tallized with one DMSO molecule in the monoclinic P21 space group,
together with the atom labeling scheme is shown in Fig. 1.
The transformed asymmetrical ligand acts a dianionic tetradentate
N,N,N,S-donor, coordinating to the platinum(II) center in a squarePlease cite this article as: A.I. Matesanz, P. Souza, Unprecedented Pt(II)
thiosemicarbazone) ligand, Inorg. Chem. Commun. (2012), http://dx.doplanar geometry through the Npyridinic atom and the Niminic and the
S atoms from one thiosemicarbazone arm. The fourth coordination
position is occupied by the Nhydrazinic atom of the other arm generating
two typical ﬁve membered (PtSCNN and PtNCCN) and one six mem-
bered (PtNNCCN) chelate rings. Coordination by the Nhydrazinic instead
of the Niminic atom, although uncommon, has been found in the bibliog-
raphy for some palladium and nickel bis(thiosemicarbazone) com-
plexes [28–30].
The Pt\N [1.979(7), 2.021(8) and 2.023(8) Å] and Pt\S [2.289(2) Å]
bond distances are comparable with those reported for Pt(II) thiosemi-
carbazone complexes.
Since the two thiosemicarbazone moieties coordinate in a differ-
ent fashion it would expect that in the bidentate-N∧S arm, the C\S
distance undergoes signiﬁcant evolution from the thione to the
thiol form [C\S distance of 1.752(9) Å] but it is important to
note that the monodentate-Nhydrazinic thiosemicarbazone arm also
presents thiol C\S bond [1.81(3) Å] as well as an unexpected S\H
bond.
It iswell known that compounds containing thiosemicarbazone func-
tional groups exhibit thiol–thione tautomerism, but unsubstituted and
monosubstituted ones, >C_N\NH\C(S)\NHR, are capable of stabiliz-
ing a third thiol form (Scheme2). This is consistentwith the C(15)\N(5)
and C(17)\N(7) bond lengths [1.309(17) and 1.295(17) Å respectively]
which correspond formally to double bondswhile the C(17)\N(6) bond
length is longer, 1.408(13) Å.
On the other hand, along the bidentate thiosemicarbazone arm and
as consequence of the extensive delocalization of electron density, thecomplex of an asymmetric 2,6-diacetylpyridine bis(4N-substituted
i.org/10.1016/j.inoche.2012.10.022
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Scheme 2.Q3
3A.I. Matesanz, P. Souza / Inorganic Chemistry Communications xxx (2012) xxx–xxxC\N and N\N bond distances are intermediate between formal single
and double bonds.
Inspection of the angles formed between the platinum(II) ion and
the coordinated atoms shows that the metal is contained within a
slightly distorted square-planar environment. The distortion is caused
by the restricted bite angle of the N(4), N(3), and S(1) donor set as
reﬂected in the S(1)\Pt(1)\N(3) and N(3)\Pt(1)\N(4) angles (less
than 90°). The angles N(4)\Pt(1)\N(6) and N(6)\Pt(1)\S(1) are
therefore greater than 90°.
The crystal structure is stabilized by intermolecular hydrogen in-
teraction involving the N(1) atom of the bidentate thiosemicarbazone
arm and the oxygen atom of the DMSO solvent molecule. Within each
molecule, the bis(thiosemicarbazone)-platinum moiety is close to
planar, so the supramolecular association also involves π–π stacking
interactions between parallel layers of molecules (Fig. 2).217
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with the Cambridge Crystallographic Data Centre. CCDC 890162 con-
tains the supplementary crystallographic data for this paper. These
data can be obtained free of charge via http://www.ccdc.cam.ac.uk/
conts/retrieving.html, or from the Cambridge Crystallographic Data
Centre, 12 Union Road, Cambridge CB21EZ, UK; fax: +44 1223 336
408; e-mail: deposit@ccdc.cam.ac.uk. Supplementary data to this arti-
cle can be found online at http://dx.doi.org/10.1016/j.inoche.2012.10.
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Fig. 2. View of platinum(II) complex [PtL2] showing the parallel disposition of the
molecules as a result of π–π stacking interactions.
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